Chia Tai Tianqing Pharmaceutical Group Co Ltd

We track 3 ClinicalTrials.gov studies led by Chia Tai Tianqing Pharmaceutical Group Co Ltd. The portfolio skews toward Phase 2 (2 trials).

3 clinical trials sponsored by Chia Tai Tianqing Pharmaceutical Group Co Ltd.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 2
67%
Phase 3 1
33%

Trial Status Breakdown

Trials by Chia Tai Tianqing Pharmaceutical Group Co Ltd

Evaluation of the Efficacy and Safety of TQB3616 Capsules Combined With Hormonal Therapy in a Phase II Clinical Trial for Cyclin-dependent Kinases 4 and 6（CDK4/6)Inhibitor-Resistant, Hormone Receptor(HR)-Positive, Human Epidermal Growth Factor Receptor 2(HER2)-Negative Recurrent/Metastatic Breast Cancer

NCT06702618 · ACTIVE NOT RECRUITING · Phase 2

A Phase III,Randomized, Double-blind, Paralle, Multi-center Study to Evaluate the Efficacy and Safety of TQB3616 Capsules Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Participants With Hormone Receptor (HR)-Positive, Human Epidermal Growth Factor Receptor(EGFR) 2-Negative Advanced Breast Cancer

NCT05375461 · COMPLETED · Phase 3

A Open-label, Multicenter Phase II Study of TQB3616 Capsules Combined With Fulvestrant Injection in Subjects With HR-positive, HER2-negative Advanced Breast Cancer

NCT04796623 · COMPLETED · Phase 2

Frequently Asked Questions

How many clinical trials does Chia Tai Tianqing Pharmaceutical Group Co Ltd sponsor?

Chia Tai Tianqing Pharmaceutical Group Co Ltd currently sponsors 3 clinical trials tracked on ReadTheTrial. These span Phase 2, Phase 3.

What conditions does Chia Tai Tianqing Pharmaceutical Group Co Ltd research?

Chia Tai Tianqing Pharmaceutical Group Co Ltd conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Chia Tai Tianqing Pharmaceutical Group Co Ltd recruiting for clinical trials?

Check the trial listings below for current recruitment status. Trial recruitment status can change frequently.

Explore More